India, April 11 -- AstraZeneca PLC (AZN.L) Friday announced that all resolutions at its Annual General Meeting were approved by shareholders, with overwhelming support across the board.
Special resolutions, including share buybacks and shortened meeting notices, passed with strong majorities, while ordinary resolutions such as approving the 2024 accounts and confirming dividends-received near-unanimous backing. Notably, PricewaterhouseCoopers LLP was re-appointed as auditor, and all board members up for election were re-elected with over 99 percent support.
Directors were also authorized to issue shares, make limited political donations, and disapply pre-emption rights to allow financial flexibility. Retiring board members Deborah DiSanzo...